Opportunistic Infections - 166 Studies Found
| Completed |
: When to Start Anti-HIV Drugs in Patients With Opportunistic Infections :
: 2003-02-19 :
|
| Not yet recruiting |
: Cryptococcal Antigen Screening Plus Sertraline :
|
| Completed |
: Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity : Kaposi´s Sarcoma : 2011-02-15 : Drug: Bevacizumab Intralesional bevacizumab, dosis of 5mg/cm2, injections every 2 weeks, total number of |
| Completed |
: Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma :
: 2010-01-26 : Drug: Lenalidomide Lenalidomide is administered daily on days 1-21 of a 28-day cycle. The maximum durati |
| Completed |
: Interleukin-12 in Treating Patients With AIDS-Related Kaposi's Sarcoma :
: 2007-03-01 : Drug: interleukin-12 |
| Completed |
: Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's Sarcoma : AIDS-related Kaposi Sarcoma : 1999-11-01 :
|
| Withdrawn |
: Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma :
|
| Active, not recruiting |
: Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma :
|
| Completed |
: AIDS and Cancer Specimen Bank (ACSB) :
|
| Completed |
: A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma :
: 1999-11-02 : Drug: TNP-470 |